When St. Louis attorney Anthony Gray discovered that the U.S. Food and Drug Administration had warned that the long-term use of the diabetes drug Actos (pioglitazone) places diabetics at an increased risk of developing bladder cancer, he took particular note.
Once he knew that bladder cancer is related to type 2 diabetes, he instantly became highly concerned as he knew that diabetes has a disproportionate impact on the African-American community.
Many people will be affected. However, they are not aware of this.
Gray is an attorney with Johnson Gray. His firm is partnering with Kelley Law Group PC in Boston, along with the law firm Goldenberg Heller in Edwardsville, for securing compensation for damages incurred by bladder cancer patients who were taking Actos. Actos is manufactured by Japan's biggest drugmaker, Takeda Pharmaceutical.
The basis for the FDA warning is a five-year interim data analysis of a ten year study. A prior French study concluded that long-term use of Actos and higher cumulative doses considerably heightened the risk of bladder cancer. Germany does not permit new patients to use the drug.
Diabetics Susceptible to Bladder Cancer
Thu, 19 Jan 2012
Recommended links
Diabetic Health Insurance for a Single PersonDiabetic Health Insurance for a Couple
Diabetic Health Insurance for a Family
Diabetic Health Insurance for a Single Parent
Diabetic Life Insurance
Diabetes Shop
Actos and Diabetes
What is covered by Diabetic Health Insurance
How Diabetes Private Medical Insurance Policies Work
Sleeping Problems can Adversely Impact Teenage Diabetics
Diabetes Could Make you Look Older
Diabetes Control with Diabetic Products
Novo Nordisk Launches Diabetes Drug Victoza in China
Good Fat Needs to be Activated to Combat Diabetes
Type 2 Diabetes
ContentMain
